Bone markers and cardiovascular risk in type 2 diabetes patients

Sabine R. Zwakenberg, Yvonne T. van der Schouw, Casper G. Schalkwijk, Annemieke M. W. Spijkerman, Joline W. J. Beulens

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number45
Number of pages7
JournalCardiovascular Diabetology
Volume17
DOIs
Publication statusPublished - 23 Mar 2018

Keywords

  • Osteocalcin
  • Osteonectin
  • Osteopontin
  • Osteoprotegerin
  • Sclerostin
  • Alkaline phosphatase
  • Cardiovascular disease
  • CORONARY-ARTERY-DISEASE
  • VASCULAR CALCIFICATION
  • CIRCULATING SCLEROSTIN
  • ALKALINE-PHOSPHATASE
  • OLDER MEN
  • EPIC-NL
  • OSTEOPONTIN
  • COHORT
  • MORTALITY
  • METAANALYSIS

Cite this

Zwakenberg, S. R., van der Schouw, Y. T., Schalkwijk, C. G., Spijkerman, A. M. W., & Beulens, J. W. J. (2018). Bone markers and cardiovascular risk in type 2 diabetes patients. Cardiovascular Diabetology, 17, [45]. https://doi.org/10.1186/s12933-018-0691-2